Highlands Oncology Group SC-1 — Fayetteville, Arkansas

Highlands Oncology Group SC-1 is a clinical research site located in Fayetteville, Arkansas, United States 72703.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Highlands Oncology Group SC-1 has participated in 1 clinical trials.

Therapeutic areas: Squamous Non-small Cell Lung Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Highlands Oncology Group SC-1?

Highlands Oncology Group SC-1 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Highlands Oncology Group SC-1 conducted?

Highlands Oncology Group SC-1 has 1 clinical trials on record. Their work covers Squamous Non-small Cell Lung Cancer.

Is Highlands Oncology Group SC-1 accredited by Crixeo Health?

Highlands Oncology Group SC-1 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Highlands Oncology Group SC-1?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.